English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Tuesday, February 25, 2020
COMM's New Project Launch Integrates Publisher and Hedge Funds on Blockchain
12:55 HKT/SGT
内房需求稳 趁机吸纳银城国际
11:53 HKT/SGT
內房需求穩 趁機吸納銀城國際
11:52 HKT/SGT
Food Empire's FY2019 net profit jumps 44.9% to a record US$25.7 million
11:00 HKT/SGT
百盛公布集团截至二零一九年十二月三十一日止之全年业绩
11:00 HKT/SGT
WEC 2019-2020年 第5戦 ローン・スター・ル・マン 決勝:TOYOTA GAZOO Racing、2台共に表彰台フィニッシュでランキング首位を堅守
11:00 HKT/SGT
NECファシリティーズ、環境試験装置トップメーカーであるエスペック株式会社 豊田試験所のグローバル規格対応リニューアル工事を完工
11:00 HKT/SGT
百盛公佈集團截至二零一九年十二月三十一日止之全年業績
10:59 HKT/SGT
Parkson Announces the Annual Results for the Year Ended 31 December 2019
10:58 HKT/SGT
NECソリューションイノベータ、再雇用制度の対象者を拡大
10:00 HKT/SGT
エーザイと富士薬品、痛風・高尿酸血症治療剤ドチヌラドについて中国における開発・販売に関するライセンス契約を締結
10:00 HKT/SGT
賽伯樂國際擬收購杭州旭航
09:01 HKT/SGT
Cybernaut International Signs Letter of Intent To Acquire Hangzhou Xuhang
09:00 HKT/SGT
Double Podium for TOYOTA GAZOO Racing in Austin
08:41 HKT/SGT
Eisai and FUJI YAKUHIN Conclude License Agreement Concerning the Development and Distribution of Dotinurad, a Treatment for Hyperuricemia and Gout, in China
08:10 HKT/SGT
Tomini Shipping Approved and Registered for Listing on the NOTC
01:00 HKT/SGT
Monday, February 24, 2020
知临集团开始商业化山药生物活性营养片剂并在香港签署销售分销协议
20:16 HKT/SGT
知臨集團開始商業化山藥生物活性營養片劑並在香港簽署銷售分銷協議
20:15 HKT/SGT
NanoViricides has filed Quarterly Report for period ending December 31, 2019; Sufficient Cash, HerpeCide(TM) Drug Candidate IND Application Development in Progress
20:15 HKT/SGT
Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong
20:13 HKT/SGT
上海餐饮一哥顺风股份(870798)将迎来“报复式”的增长
17:09 HKT/SGT
上海餐飲一哥順風股份(870798)將迎來“報復式”的增長
17:08 HKT/SGT
ERB secures US$1 billion from McKINLEY to Rethink Risk in SE Asia Markets
16:10 HKT/SGT
Davis Index launches world's only Market Price Platform built for Metals Recycling Industry
12:10 HKT/SGT
众多利好!DB3数字货币电子银行即将于2020年隆重启幕!
11:27 HKT/SGT
眾多利好!DB3數位貨幣電子銀行即將於2020年隆重啟幕!
11:26 HKT/SGT
VPower Group Signs New Contract Aggregating a Total Installed Capacity of Close to 100MW in Sri Lanka
10:15 HKT/SGT
伟能集团于斯里兰卡签订新合约 于当地的总装机容量将增加至接近100兆瓦
09:07 HKT/SGT
偉能集團於斯里蘭卡簽訂新合約 於當地的總裝機容量將增加至接近100兆瓦
09:06 HKT/SGT
VPower Group Signs New Contract Aggregating a Total Installed Capacity of Close to 100MW in Sri Lanka
09:05 HKT/SGT
Honda、フィリピンにおける四輪完成車生産の終了について
09:00 HKT/SGT
维亚生物获纳入恒生综合指数等7个指数 将成为深港通目标
07:34 HKT/SGT
維亞生物獲納入恒生综合指數等7個指數 將成為深港通標的
07:33 HKT/SGT
Viva Biotech Included as Constituent Stock of Hang Seng Composite Index and Other 6 Indexes, Becoming an Eligible Stock of Shenzhen-Hong Kong Stock Connect
07:32 HKT/SGT
Saturday, February 22, 2020
The Closure of Automobile Production in the Philippines
17:00 HKT/SGT
Friday, February 21, 2020
安捷证券:写在内地疫情拐点可能来临之际
21:23 HKT/SGT
安捷證券:寫在內地疫情拐點可能來臨之際
21:21 HKT/SGT
Uniting Hong Kong People to Fight the Coronavirus, Chun Wo Charitable Foundation Donates over 200,000 Surgical Masks and HK$400,000
17:37 HKT/SGT
Eisai Receives the President's Award of the Japan Techno-Economics Society at the 8th Technology Management and Innovation Awards
16:55 HKT/SGT
MHPS Receives 12 Year Maintenance Service Extension for the BLCP Power Station in Thailand
15:07 HKT/SGT
三菱電機、「火星衛星探査計画(MMX)探査機システム」の本格的な開発に着手
15:00 HKT/SGT
トヨタ・モビリティランド・Honda、「モースポフェス2020 SUZUKA~モータースポーツファン感謝デー~」の開催中止について
13:00 HKT/SGT
與香港人同心抗疫 俊和慈善基金捐贈逾20萬個口罩及捐款40萬港元
12:34 HKT/SGT
NEC、六本木に石井幹子氏・石井リーサ明理氏デザインによるAIを搭載した「スマート街路灯」を設置
11:00 HKT/SGT
三菱電機、サンガスタジアム by KYOCERA向けに複数の映像装置を一括納入
10:00 HKT/SGT
 ACN Search:
 
Roughly 265,000 of our Indonesian countrymen living and working in Hong Kong need masks to protect them from the coronavirus. Let's move, and help to send masks!
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>

11 Biggest ICO ROIs Of 2018

Infographic source:

https://icowatchlist.com

Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575